MétaCan
Menu
Back to cohort
Record W4413384329 · doi:10.1016/j.jhepr.2025.101560

Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis

2025· article· en· W4413384329 on OpenAlexafffund
Lesley A. Patmore, Lilian Yan Liang, George Papatheodoridis, Mai Kilany, Arno Furquim d’Almeida, Vincent Wai‐Sun Wong, Μargarita Papatheodoridi, Thomas Vanwolleghem, Pieter Honkoop, Hans Blokzijl, Özgür M. Koc, Harry L.A. Janssen, Matthijs Kramer, Joep de Bruijne, Apichat Kaewdech, Robert A. de Man, R. Bart Takkenberg, Grace Lai‐Hung Wong, Jordan J. Feld, Milan J. Sonneveld

Bibliographic record

VenueJHEP Reports · 2025
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsToronto General Hospital
FundersStichting voor Lever- en Maag-Darm OnderzoekVlaamse regeringFaculty of Medicine, Prince of Songkla UniversityIpsenNational and Kapodistrian University of AthensPrince of Songkla UniversityNorgineFonds Wetenschappelijk OnderzoekChinese University of Hong KongMaastricht Universitair Medisch CentrumRijksuniversiteit GroningenJanssen PharmaceuticalsAmsterdam University Medical CentersGilead SciencesUniversity of TorontoAmgenUniversiteit MaastrichtGlaxoSmithKlineUniversitair Medisch Centrum GroningenBristol-Myers SquibbNovo NordiskAbbott Laboratories
KeywordsHepatocellular carcinomaMedicineChronic hepatitisFibrosisLiver fibrosisGastroenterologyInternal medicineCarcinomaOncologyImmunologyVirus

Abstract

fetched live from OpenAlex

Background & Aims Chronic hepatitis B (CHB) patients with advanced fibrosis are at high risk for hepatocellular carcinoma (HCC). Liver stiffness measurement (LSM) correlates with fibrosis in untreated patients, and is used to monitor changes in severity of liver disease. However, the association between on-treatment LSM and HCC risk is controversial. Methods We conducted an international multicenter retrospective cohort study of CHB patients with advanced fibrosis and assessed the association between on-treatment LSM, HCC development and decompensation events. Results We analyzed 562 patients (62.8% F4, 69.2% Asian). During antiviral therapy, the on-treatment LSM decreased to <6 kPa in 209 (37.2%), to 6-9 kPa in 174 (31.0%) and remained >9 kPa in 179 (31.9%) patients. During a median follow-up of 6.8 years after the on-treatment LSM, 56 patients developed HCC, 18 (32.2%) had an on-treatment LSM <6 kPa. The 5-year cumulative HCC incidence was comparable across on-treatment LSM strata; 4.4% for <6 kPa, 5.5% for 6-9 kPa and 5.8% for >9 kPa (p=0.300). In multivariable analysis, older age (adjusted Hazard Ratio [aHR] 1.058, 95% CI 1.026 – 1.091, p<0.001) and lower platelet count (aHR 0.992, 95% CI 0.992 – 0.998, p=0.005) were associated with HCC development, whereas on-treatment LSM was not (aHR 0.974, p=0.974). In contrast, patients with an LSM decrease to ≤9 kPa had a negligible risk of decompensation (0% vs 1.8% at 5 years, p=0.017). Conclusions Most chronic hepatitis B patients with advanced fibrosis decrease in liver stiffness measurement during antiviral therapy. Although a decrease in liver stiffness was associated with a lower risk of decompensation, an improvement in liver stiffness was not associated with a reduction in hepatocellular carcinoma risk.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.012
Threshold uncertainty score0.516

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.199
Teacher spread0.194 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJHEP ReportsSame topicLiver Disease Diagnosis and TreatmentFrench-language works237,207